EGF and hepatocellular carcinoma: Association of the EGF 61*A/A genotype with decreased HCC risk was observed in the total population in the dominant genetic model (OR = 0.66, 95% CI = 0.53–0.83, P<0.001; I2 = 0%) (Fig. 2.